Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-05-30 @ 3:49 AM
Study NCT ID:
NCT00224120
Status:
COMPLETED
Last Update Posted:
2009-12-15
First Post:
2005-09-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
Sponsor:
Watson Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SI04010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gary Hoel, RPh, PhD, Executive Director of Clinical Research
Old Organization:
Watson Laboratories, Inc.